3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Leukemia, Myeloid, Acute
4
Burkitt Lymphoma
4
Myelodysplastic Syndromes
3
Multiple Myeloma
2
Ganglioneuroblastoma
2
Smoldering Multiple Myeloma
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Neuroblastoma
1
Myeloproliferative Disorders
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Prolymphocytic
1
Leukemia, Plasma Cell
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Biphenotypic, Acute
1
Hodgkin Disease
1
Interventions
Whole-Body Irradiation
2
Peripheral Blood Stem Cell Transplantation
2
Cyclophosphamide
2
fludarabine phosphate
1
fludarabine
1
Tacrolimus
1
Sirolimus
1
Mycophenolic Acid
1
Methotrexate
1
Melphalan
1
Etoposide
1
Cyclosporine
1
Busulfan
1
Antilymphocyte Serum
1
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anemia, Aplastic
×
Stem Cell Transplantation
×
30 days
×
Clear all
No trials found.